SUNNYDAY: SUbepithelialgastroiNtestiNal Tumors Detection,accuracYDiAgnosis,ElastographY and Contrast-enhanced EUS
NCT ID: NCT06324032
Last Updated: 2024-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
138 participants
OBSERVATIONAL
2020-12-17
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
EUS-Elastography and Contrast-Enhanced EUS Diagnostic Accuracy in the Differential Diagnosis of Subepithelial Gastrointestinal Tumors
NCT04695262
Serial Ultrasound of Solid Tumor Lesions to Detect Early Response to Cancer Immunotherapy
NCT05206942
Comparison of the Diagnostic Accuracy: US-guided Percutaneous Lung Biopsies vs CT-guided in Peripheral Lung Lesions
NCT06412289
High Frequency Intraoral Ultrasound Probe for Early Diagnosis of Periodontal Diseases
NCT05809427
"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)
NCT06336941
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with subepithelial gastrointestinal tumors
Patients with subepithelial gastrointestinal tumors
EUS Elastography (EUS-E)
All procedures will be performed with Olympus echoendoscopes (Olympus Europa SE \& CO. KG, Hamburg, Germany) or Pentax echoendoscopes in combination with dedicated elastography software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EUS Elastography (EUS-E)
All procedures will be performed with Olympus echoendoscopes (Olympus Europa SE \& CO. KG, Hamburg, Germany) or Pentax echoendoscopes in combination with dedicated elastography software
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. severe coagulopathy defined as abnormal prothrombin time (PT) or partial thromboplastin time (PTT) that does not normalize after administration of fresh frozen plasma
3. severe cardiopulmonary diseases and severe chronic kidney disease defined as
4. known allergic disposition to SonoVue®
5. pregnancy
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione del Piemonte per l'Oncologia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Teresa Staiano, MD
Role: PRINCIPAL_INVESTIGATOR
FPO-IRCCS di Candiolo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ospedale Santa Maria della Scaletta
Imola, Bologna, Italy
Istituto Clinico Humanitas
Rozzano, Milano, Italy
Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
Candiolo, Turin,, Italy
Ospedale Humanitas Mater Domini
Castellanza, Varese, Italy
AOU Maggiore della Carità
Novara, , Italy
Istituto Oncologico Veneto
Padua, , Italy
AOU Città della Salute e della Scienza di Torino, Ospedale Molinette
Turin, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Pietro Fusaroli, MD
Role: primary
Silvia Carrara, MD
Role: primary
Benedetto Mangiavillano, MD
Role: primary
Pietro Occhipinti, MD
Role: primary
Alberto Fantin, MD
Role: primary
Claudio G. De Angelis, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
021-FPO20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.